Diatreme Resources Ltd has announced a Priority Offer in the Moonlight Resources IPO Prospectus, fully underwritten at $3.0 million for DRX shareholders, priced at $0.20 per ordinary Moonlight share. Participating shareholders receive a free attaching option for every two shares acquired. Diatreme entered a Share Sale Agreement with Moonlight to sell shares in subsidiaries Chalcophile and PGE Minerals, receiving 16.25 million ordinary Moonlight shares valued at $3.25 million and $250,000 in cash. Diatreme shareholders as of 28 October 2025 can access a priority offer. Moonlight's IPO Prospectus is lodged with ASIC. The Clermont asset sale allows Diatreme to focus on its core silica assets.
Key Points
DRX Shareholders Priority Offer in Moonlight Resources IPO Prospectus.
Fully underwritten Priority Offer of $3.0m to DRX shareholders at an issue price of $0.20 per fully paid ordinary Moonlight share.
Shareholders that participate in Moonlight’s offer will receive one free attaching option for every two new Moonlight shares acquired under the IPO.
Diatreme Resources Ltd entered into a Share Sale Agreement with Moonlight Resources Limited to sell shares in Chalcophile Resources Pty Ltd and PGE Minerals Pty Limited.
Moonlight will issue 16,250,000 ordinary shares to Diatreme, corresponding to a total value of $3,250,000, and pay A$250,000 in cash.
Diatreme Shareholders as at 28 October 2025 will receive a priority offer from Moonlight of up to $3.0m shares at an issue price of $0.20.
Moonlight has lodged its IPO Prospectus with ASIC, available on their website.
The Clermont asset is non-core to Diatreme, focusing on silica assets.
Key commercial terms include no performance rights for Diatreme, and additional warranties related to Chalcophile and PGE Minerals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.